ArticleBlood cancer journal2025

The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience.

Aimaz Afrough et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.